SPGI vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

SPGI

46.2
AI Score
VS
CME Wins

CME

46.6
AI Score

Investment Advisor Scores

SPGI

46score
Recommendation
HOLD

CME

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SPGI CME Winner
Revenue 4.17B 3.59B SPGI
Net Income 1.40B 2.20B CME
Net Margin 33.4% 61.2% CME
Operating Income 2.00B 2.42B CME
ROE 4.5% 8.3% CME
ROA 2.3% 1.1% SPGI
Total Assets 60.79B 194.68B CME
Cash 1.81B 2.14B CME
Current Ratio 0.68 1.02 CME

Relative Price Performance (Last 90 Days)

SPGI 1M: +0.1% · 3M: -0.6% CME 1M: +5.1% · 3M: +5.1%

Current Technical Phase

SPGI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.8 · Price: $410.71

CME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.9% over 20 days), RSI 53

RSI (14): 53.1 · Price: $275.54

Fundamentals Snapshot

Metric SPGI CME
Market Cap
Forward P/E 20.3 21.3
Trailing P/E 25.0 23.3
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% 1.0%
Operating Margin 0.4% 0.7%
EPS 16.42 11.78
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.